“…"H 2 S-Rich" and "H 2 S-Poor" Pathophysiological Conditions H 2 S has been implicated in the pathogenesis of multiple diseases, as overviewed in review articles. These range from cardiovascular diseases (e.g., myocardial reperfusion injury, cardiac hypertrophy, heart failure, atherosclerosis, hypertension) (Predmore et al, 2012b;Polhemus and Lefer, 2014;Ahmad et al, 2015;Meng et al, 2015aMeng et al, , 2016Shen et al, 2015;Wang et al, 2015a;Cao and Bian, 2016;Kanagy et al, 2017;Greaney et al, 2017) to various neurologic diseases (e.g., stroke, neuroinflammation) (Wang et al, 2014a;Bhatia, 2015;Kida and Ichinose, 2015;Wallace et al, 2015;Sen, 2017) and metabolic diseases (e.g., diabetes mellitus) (Desai et al, 2011;Szabo, 2012;Okamoto et al, 2015;Carter and Morton, 2016) to various forms of local and systemic inflammation (e.g., hemorrhagic shock, septic H 2 S Donors and H 2 S Biosynthesis Inhibitors shock, burn injury) (Wagner et al, 2009;Coletta and Szabo, 2013;McCook et al, 2014;Akter, 2016).…”